Welcome
Support Centre
19 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A Randomised Trial of Conformal versus Conventional Radiotherapy in Pelvic Neoplasms
ISRCTN ISRCTN17264730
ClinicalTrials.gov identifier
Public title A Randomised Trial of Conformal versus Conventional Radiotherapy in Pelvic Neoplasms
Scientific title
Acronym N/A
Serial number at source ICR/PELVIC
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer: Bladder (advanced), Bladder (superficial), Multiple Sites, Prostate, Rectum
Participants - inclusion criteria 1. Carcinoma of the pelvic region (eg prostate, bladder, rectum, etc)
2. Patients scheduled to undergo pelvic radiotherapy by a CT planned technique with less than four fields provided a satisfactory localisation on the simulator can be achieved
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2001
Anticipated end date 31/12/2001
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions 1. Group A: Conventional radiotherapy using a three field technique employing rectangular fields. Suggested dosage, 64 Gy in 2 Gy fractions five times a week
2. Group B: Conformal radiotherapy using a three field technique employing fields shaped with customised blocks drawn according to the beam's-eye view of the target volume. Suggested dosage, 64 Gy in 2 Gy fractions five times a week.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Institute of Cancer Research (UK)
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email register@ctu.mrc.ac.uk
Sponsor The Institute of Cancer Research (UK)
  Address 123 Old Brompton Road
  City/town London
  Zip/Postcode SW7 3RP
  Country United Kingdom
  Tel +44(0) 20 7352 8133
  Fax +44(0) 20 7370 5261
  Email
  Sponsor website: http://www.icr.ac.uk
Date applied 19/08/2002
Last edited 17/12/2007
Date ISRCTN assigned 19/08/2002
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central